DelveInsight has launched a new report on “Acute Myeloid Leukemia – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Acute Myeloid Leukemia – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Acute Myeloid Leukemia, historical and forecasted epidemiology as well as the Acute Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
AML accounts for <3% of all cancers, and 25% of all leukemia in adults. Worldwide, the incidence of AML was reported to be highest in the US, Australia, and Western Europe. The incidence has been near stable over the last years.
The incidence continuously shows 2 peaks in occurrence in early childhood and later adulthood. From 2000 to 2003, the US incidence rate in people age
The Surveillance has reported an AML incidence rate of 3.7 per 100,000 inhabitants in Europe with a 5-year survival rate of 19%.
Key benefits of the report:
Acute Myeloid Leukemia market report covers a descriptive overview and comprehensive insight of the Acute Myeloid Leukemia Epidemiology and Acute Myeloid Leukemia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Acute Myeloid Leukemia market report provides insights on the current and emerging therapies.
Acute Myeloid Leukemia market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Acute Myeloid Leukemia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Acute Myeloid Leukemia market.
Got queries? Click here to know more about Acute Myeloid Leukemia Market Landscape.
Acute Myeloid Leukemia Overview
Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. The word “acute” in acute myelogenous leukemia denotes the disease’s rapid progression. It’s called myelogenous leukemia because it affects a group of white blood cells called the myeloid cells, which normally develop into the various types of mature blood cells, such as red blood cells, white blood cells, and platelets.
The key players involved in the Acute Myeloid Leukemia market:
AVEO Oncology and Biodesix
The launch of the emerging therapies is expected to significantly impact the Acute Myeloid Leukemia treatment scenario in the upcoming years:-
omab-B CD45 and Actimab-A CD33
Table of Contents:
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Acute Myeloid Leukemia Patient Share (%) Overview at a Glance
5. Acute Myeloid Leukemia Market Overview at a Glance
6. Acute Myeloid Leukemia Disease Background and Overview
7. Acute Myeloid Leukemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute Myeloid Leukemia
9. Acute Myeloid Leukemia Current Treatment and Medical Practices
10. Unmet Needs
11. Acute Myeloid Leukemia Emerging Therapies
12. Acute Myeloid Leukemia Market Outlook
13. Country-Wise Acute Myeloid Leukemia Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Acute Myeloid Leukemia Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
“Acute Myeloid Leukemia Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Acute Myeloid Leukemia market. A detailed picture of the Acute Myeloid Leukemia pipeline landscape is provided, which includes the disease overview and Acute Myeloid Leukemia treatment guidelines.
DelveInsight’s ‘Acute Myeloid Leukemia Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Acute Myeloid Leukemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States